The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC
Condition: Hepatitis B Interventions: Drug: Peginterferon Alfa-2A; Drug: Adefovir, entecavir,tenofovir, either of them Sponsor: Shanghai Nanhui Nanhua Hospital Active, not recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials